These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 9144102)

  • 21. Anosognosia in Alzheimer's disease: relationships to depression, cognitive function, and cerebral perfusion.
    Reed BR; Jagust WJ; Coulter L
    J Clin Exp Neuropsychol; 1993 Mar; 15(2):231-44. PubMed ID: 8491848
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anosognosia and Alzheimer's disease: the role of depressive symptoms in mediating impaired insight.
    Smith CA; Henderson VW; McCleary CA; Murdock GA; Buckwalter JG
    J Clin Exp Neuropsychol; 2000 Aug; 22(4):437-44. PubMed ID: 10923053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship of cognitive and functional impairment to depressive features in Alzheimer's disease and other dementias.
    Payne JL; Lyketsos CG; Steele C; Baker L; Galik E; Kopunek S; Steinberg M; Warren A
    J Neuropsychiatry Clin Neurosci; 1998; 10(4):440-7. PubMed ID: 9813790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Psychostimulants in post-stroke depression.
    Masand P; Murray GB; Pickett P
    J Neuropsychiatry Clin Neurosci; 1991; 3(1):23-7. PubMed ID: 7580168
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cognitive reserve and the relationship between depressive symptoms and awareness of deficits in dementia.
    Spitznagel MB; Tremont G; Brown LB; Gunstad J
    J Neuropsychiatry Clin Neurosci; 2006; 18(2):186-90. PubMed ID: 16720795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Depressive symptoms in the preclinical period of dementia of the Alzheimer's type].
    Bidzan L
    Psychiatr Pol; 1999; 33(5):747-60. PubMed ID: 10761440
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methylphenidate in post liver transplant patients.
    Plutchik L; Snyder S; Drooker M; Chodoff L; Sheiner P
    Psychosomatics; 1998; 39(2):118-23. PubMed ID: 9584537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methylphenidate for alpha-interferon induced depression.
    Camacho A; Ng B
    J Psychopharmacol; 2006 Sep; 20(5):687-9. PubMed ID: 16533869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Denial of memory deficit in Alzheimer's disease.
    Sevush S; Leve N
    Am J Psychiatry; 1993 May; 150(5):748-51. PubMed ID: 8480820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel multidomain computerized cognitive assessment for attention-deficit hyperactivity disorder: evidence for widespread and circumscribed cognitive deficits.
    Leitner Y; Doniger GM; Barak R; Simon ES; Hausdorff JM
    J Child Neurol; 2007 Mar; 22(3):264-76. PubMed ID: 17621495
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The specificity of depressive symptoms in patients with Alzheimer's disease.
    Chemerinski E; Petracca G; Sabe L; Kremer J; Starkstein SE
    Am J Psychiatry; 2001 Jan; 158(1):68-72. PubMed ID: 11136635
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlates of health-related quality of well-being in older patients with schizophrenia.
    Mittal D; Davis CE; Depp C; Pyne JM; Golshan S; Patterson TL; Jeste DV
    J Nerv Ment Dis; 2006 May; 194(5):335-40. PubMed ID: 16699382
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Attention-deficit/hyperactivity disorder and comorbid subsyndromal depression: what is the impact of methylphenidate on mood?
    Golubchik P; Kodesh A; Weizman A
    Clin Neuropharmacol; 2013; 36(5):141-5. PubMed ID: 24045603
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cognitive functioning in late-life schizophrenia: a comparison of elderly schizophrenic patients and patients with Alzheimer's disease.
    Davidson M; Harvey P; Welsh KA; Powchik P; Putnam KM; Mohs RC
    Am J Psychiatry; 1996 Oct; 153(10):1274-9. PubMed ID: 8831434
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methylphenidate for apathy and functional status in dementia of the Alzheimer type.
    Padala PR; Burke WJ; Shostrom VK; Bhatia SC; Wengel SP; Potter JF; Petty F
    Am J Geriatr Psychiatry; 2010 Apr; 18(4):371-4. PubMed ID: 20220576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuropsychological dysfunction in antipsychotic-naive first-episode unipolar psychotic depression.
    Hill SK; Keshavan MS; Thase ME; Sweeney JA
    Am J Psychiatry; 2004 Jun; 161(6):996-1003. PubMed ID: 15169687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cognitive deficits in olivopontocerebellar atrophy: implications for the cholinergic hypothesis of Alzheimer's dementia.
    Kish SJ; el-Awar M; Schut L; Leach L; Oscar-Berman M; Freedman M
    Ann Neurol; 1988 Aug; 24(2):200-6. PubMed ID: 3178175
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Depression and Alzheimer's disease.
    Rovner BW; Broadhead J; Spencer M; Carson K; Folstein MF
    Am J Psychiatry; 1989 Mar; 146(3):350-3. PubMed ID: 2919692
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurocognitive differential diagnosis of dementing diseases: Alzheimer's Dementia, Vascular Dementia, Frontotemporal Dementia, and Major Depressive Disorder.
    Braaten AJ; Parsons TD; McCue R; Sellers A; Burns WJ
    Int J Neurosci; 2006 Nov; 116(11):1271-93. PubMed ID: 17000529
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Six-year follow-up study of cognitive and functional status across the lifespan in schizophrenia: a comparison with Alzheimer's disease and normal aging.
    Friedman JI; Harvey PD; Coleman T; Moriarty PJ; Bowie C; Parrella M; White L; Adler D; Davis KL
    Am J Psychiatry; 2001 Sep; 158(9):1441-8. PubMed ID: 11532729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.